M&A Deal Summary |
|
---|---|
Date | 2018-07-30 |
Target | Immedica Pharma |
Sector | Life Science |
Buyer(s) | Impilo |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Impilo is a private investment firm focused exclusively on on investments in Nordic companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Impilo prefers majority investments, but will consider select minority situations. Target companies are generally valued between SEK 200 million and SEK 1.5 billion. Impilo has offices in Stockholm and Copenhagen.
DEAL STATS | # |
---|---|
Overall | 3 of 10 |
Sector (Life Science) | 1 of 3 |
Type (Buyout (LBO, MBO, MBI)) | 3 of 8 |
Country (Sweden) | 1 of 4 |
Year (2018) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-12-01 |
NutraQ
Oslo, Norway NutraQ is a provider of subscription-based health and wellness products in the Nordic region. NutraQ was founded in 2002 and is based in Oslo, Norway. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-01-14 |
Humana
Stockholm, Sweden Humana is a provider of personal assistance and related services for individuals with functional impairments. The Company’s offering encompasses a wide variety of services for individuals with functional impairments, including providing personal assistants, legal assistance, administrative support, assistant recruitment, and training. Humana was founded in 2000 and is based in Stockholm, Sweden. |
Buy | - |